Viking Therapeutics Inc VKTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
2.72UNCH (UNCH)
Volume
9,370
Close
2.72quote price arrow down-0.03 (-1.09%)
Volume
471,823
52 week range
2.02 - 7.05
Loading...
  • Open2.73
  • Day High2.86
  • Day Low2.68
  • Prev Close2.75
  • 52 Week High7.05
  • 52 Week High Date11/04/21
  • 52 Week Low2.02
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap208.60M
  • Shares Out76.69M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-40.87

KEY STATS

  • Open2.73
  • Day High2.86
  • Day Low2.68
  • Prev Close2.75
  • 52 Week High7.05
  • 52 Week High Date11/04/21
  • 52 Week Low2.02
  • 52 Week Low Date06/16/22
  • Market Cap208.60M
  • Shares Out76.69M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-40.87

RATIOS/PROFITABILITY

  • EPS (TTM)-0.76
  • P/E (TTM)-3.57
  • Fwd P/E (NTM)-2.83
  • EBITDA (TTM)-59.789M
  • ROE (TTM)-30.31%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Viking Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for metabolic and endocrine disorders. The Company's lead clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß). The Company is conducting VOYAGE study, a phase II b clinical trial of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis...
Lawson Macartney Ph.D.
Independent Chairman of the Board
Brian Lian Ph.D.
President, Chief Executive Officer, Director
Marianne Mancini
Chief Operating Officer
Greg Zante CPA
Chief Financial Officer
Address
9920 Pacific Heights Blvd, Suite 350
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
KRON
Kronos Bio Inc
3.35UNCHUNCH
EVLO
Evelo Biosciences Inc
2.09+0.06+2.96%
ACIU
AC Immune SA
3.16-0.13-3.95%
ABOS
Acumen Pharmaceuticals Inc
10.03-0.45-4.29%
OMIC
Singular Genomics Systems Inc
2.50-0.06-2.34%